Regulatory intelligence for stronger MedTech decisions.
The SHOTUNE Knowledge Series helps regulatory, clinical, quality, and executive leaders understand how renewal timing, clinical evidence, post-market obligations, technical documentation, and portfolio decisions connect.
Each resource translates a specific regulatory issue into the wider evidence, governance, market-continuity, and leadership decisions surrounding it.
Explore the SHOTUNE Knowledge Series
Each resource connects a specific regulatory question to the wider portfolio, evidence, governance, and market-continuity decisions surrounding it.
Knowledge Series
Why EU MDR Is a Governance Challenge: Not a Documentation Exercise
See how regulatory transitions expose misalignment across clinical evidence, quality systems, post-market obligations, technical documentation, and governance.
Primary topic: Governance
Intended audience: Regulatory, clinical, quality, and executive leaders
Date: March 5, 2026
Reading time: 6 min read
Knowledge Series
Building an Integrated PMS–PMCF–CER Engine for Portfolio Growth Under EU MDR
Explore how post-market surveillance, PMCF, clinical evaluation, technical assessment, risk management, and lifecycle evidence can operate as one continuous system.
Primary topic: Clinical Evidence and PMCF
Intended audience: Regulatory, clinical, quality, and executive leaders
Date: March 5, 2026
Reading time: 5 min read
Knowledge Series
EU MDR Portfolio Heatmaps: Turning Certificates and Risk into an Executive Dashboard
Learn how certificate timing, renewal waves, evidence gaps, document readiness, and product priorities can be translated into one leadership view.
Primary topic: Portfolio Risk
Intended audience: Regulatory, clinical, quality, and executive leaders
Date: March 5, 2026
Reading time: 4 min read
Knowledge Series
Designing Enterprise MDR Governance: From Functional Silos to Integrated Decision Councils
Review a governance approach that brings regulatory, clinical, quality, post-market, risk, and portfolio decisions into an accountable executive structure.
Primary topic: Governance
Intended audience: Regulatory, clinical, quality, and executive leaders
Date: March 5, 2026
Reading time: 6 min read
Knowledge Series
Preventing the 2026–2027 MDR Bottleneck: Certificate Cliffs, Renewal Waves, and SKU Triage
Understand how clustered renewals, constrained review capacity, product rationalization, and delayed decisions can threaten market continuity.
Primary topic: EU MDR Readiness
Intended audience: Regulatory, clinical, quality, and executive leaders
Date: March 5, 2026
Reading time: 6 min read
When insight becomes a live decision.
A resource can clarify the pattern. An independent readiness review can determine what that pattern means across technical documentation, clinical evidence, post-market files, risk conclusions, claims, and prior findings.